Showing results (331-340 of 407) with videos related to

Sort By:
Pageof 41
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with SeverityFatemeh Siavoshi, Julián Candia, Dimitrios C Ladakis, et al.
Neurology. Clinical Practice|August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centersBrandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 27, 2025
Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factorsFarren Bs Briggs, Jiayue Yang, Karlo Toljan, et al.
JMIR Mhealth and Uhealth|March 31, 2025
Accelerometry-Assessed Physical Activity and Circadian Rhythm to Detect Clinical Disability Status in Multiple Sclerosis: Cross-Sectional StudyNicole Bou Rjeily, Muraleetharan Sanjayan, Pratim Guha Niyogi, et al.
Neurology|June 12, 2026
Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter StudyAlexandra Scharf, Jeffrey A Cohen, Ruth Ann Marrie, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2017
Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research prioritiesRobert W Motl, Ellen M Mowry, Dawn M Ehde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2022
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health SolutionsJeffrey A Cohen, Robert A Bermel, Cynthia I Grossman, et al.
Neurology|October 24, 2014
Protective environmental factors for neuromyelitis opticaJennifer Graves, Siri Grandhe, Kelley Weinfurtner, et al.
Multiple Sclerosis and Related Disorders|June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.
The Lancet. Neurology|August 26, 2018
Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective studyBruce D Trapp, Megan Vignos, Jessica Dudman, et al.
Pageof 41